Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Towards precision medicine in myeloma: new evidence and challenges].

Medicina - 1 Jan 2017

González-Calle Verónica, Fonseca Rafael

Abstract excerpt

In the last few years, next-generation sequencing studies have provided insights into the mutational landscape of multiple myeloma. The identification of actionable mutations might give a precious opportunity for exploring new targeted therapies. Thus, the implementation of promising precision medicine strategies seems to be closer than ever. Throughout this review we describe the main challenges that should to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Drug Therapy, Combination
Share to Multiple Myeloma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 28643680

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Towards precision medicine in myeloma: new evidence and challenges].PMID 28643680Read ↗

Liquid biopsies for multiple myeloma in a time of precision medicineSemantic proximity Read ↗

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.Semantic proximity Read ↗

Single-cell sequencing reveals the mechanisms of multiple myeloma progression: clarity or confusion?Semantic proximity Read ↗

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanismsSemantic proximity Read ↗

Where we were, where we are, where we are going: progress in multiple myeloma.Semantic proximity Read ↗

SnapShot: Multiple Myeloma.Semantic proximity Read ↗

How to use new biology to guide therapy in multiple myeloma.Semantic proximity Read ↗

Utilizing next-generation sequencing in the management of multiple myeloma.Semantic proximity Read ↗

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read ↗

Advancements in Multiple Myeloma Research: High-Throughput Sequencing Technologies, Omics, and the Role of Artificial IntelligenceSemantic proximity Read ↗

Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideSemantic proximity Read ↗

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.